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Abstract
Few analyses in the United States have examined geographic variation and socioeconomic 
disparities in amyotrophic lateral sclerosis (ALS) incidence, because of lack of population-based 
incidence data. In this analysis, we used population-based ALS data to identify whether ALS 
incidence clusters geographically and to determine whether ALS risk varies by area-based 
socioeconomic status (SES). This study included 493 incident ALS cases diagnosed (via El 
Escorial criteria) in New Jersey between 2009 and 2011. Geographic variation and clustering of 
ALS incidence was assessed using a spatial scan statistic and Bayesian geoadditive models. 
Poisson regression was used to estimate the associations between ALS risk and SES based on 
census-tract median income while controlling for age, sex, and race. ALS incidence varied across 
and within counties, but there were no statistically significant geographic clusters. SES was 
associated with ALS incidence. After adjustment for age, sex, and race, the relative risk of ALS 
was significantly higher (relative risk (RR) = 1.37, 95% confidence interval (CI): 1.02, 1.82) in the 
highest income quartile than in the lowest. The relative risk of ALS was significantly lower among 
blacks (RR = 0.57, 95% CI: 0.39, 0.83) and Asians (RR = 0.63, 95% CI: 0.41, 0.97) than among 
whites. Our findings suggest that ALS incidence in New Jersey appears to be associated with SES 
and race.
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Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a rare and fatal 
neurological disease characterized by a progressive loss of motor neurons in the brain and 
spinal cord. Currently the cause of ALS is unknown; however, a small proportion of cases 
are familial (1). The remainder of the cases, accounting for 90%–95% of all observed cases 
worldwide, are referred to as sporadic ALS. Numerous possible risk factors for sporadic 
ALS have been studied, including environmental exposures (2–4), occupational exposures 
(4–6), physical activity and trauma (7), oxidative stress (8), nutritional intake (9), and 
smoking (10, 11), but results from these studies have thus far been inconsistent and 
inconclusive.
Reported crude incidence rates of ALS worldwide currently range from 0.3 cases per 
100,000 population to 3.6 cases per 100,000 (12). The incidence of ALS increases with age, 
with the majority of cases being diagnosed at 55–75 years of age (12, 13). Men have higher 
incidence rates of ALS than women (13, 14), and data suggest a lower incidence of ALS in 
nonwhites and Hispanics compared with whites and non-Hispanics, respectively (15–17). 
Geographic areas with higher localized incidence rates of ALS (e.g., geographic clustering) 
have been reported in specific regions worldwide. The most notable examples include a 
higher incidence of the Western Pacific form of ALS in the 1950s on the island of Guam 
(18), on the Kii Peninsula in Japan (19), and in southwestern New Guinea (20).
Motivated by investigations into potential environmental causes of ALS in the Western 
Pacific and other recent reports of localized clusters of ALS elsewhere in the world (21–30), 
researchers are increasingly using spatial analysis methods to map geographic variations in 
ALS incidence and to identify localized clusters of ALS (31). The main goal of these types 
of investigations has been to locate geographic clusters of ALS and develop hypotheses 
about possible environmental risk factors responsible for the clusters (31).
While spatial analysis of disease rates provides a logical starting point for developing 
hypotheses about potential geography-based environmental risk factors, studies about 
socioeconomic variations in disease rates are also useful for formulating hypotheses about 
the role that environmental, social, and behavioral risk factors play in the development of 
disease (32, 33). For some chronic diseases, such as some cancers, associations between 
disease risk and socioeconomic status (SES) have been consistently shown (34–36). 
Surprisingly, there have only been 3 studies of the association between ALS incidence and 
SES. These studies were conducted in Finland (37), the United States (38), and Florence, 
Italy (39) more than 30 years ago, and the results were inconsistent. It remains unclear 
whether ALS is associated with SES.
To date, only a limited number of population-based studies examining geographic variation 
and socioeconomic disparities in ALS incidence have been completed in the United States, 
because of lack of data. In this investigation, we utilized ALS incidence data collected as 
part of a surveillance project funded by the Agency for Toxic Substances and Disease 
Henry et al. Page 2













Registry (40) to map the geographic variation in ALS risk in New Jersey and identify any 
evidence of geographic clustering. In addition to the spatial analysis, a secondary objective 
of this investigation was to examine whether ALS risk varies by area-based SES. To our 
knowledge, this is the first geographic analysis of ALS to have been completed for New 
Jersey and one of only a handful from the continental United States that have used 
population-based ALS incidence data rather than mortality data.
METHODS
Study population
The case data included 493 New Jersey residents diagnosed with ALS from 2009 to 2011 
that met the El Escorial criteria (41). Details about ALS case ascertainment in New Jersey 
and data collection efforts have been previously described (13). Information about patient 
demographic characteristics, including date of birth, sex, race, and ethnicity, was available. 
Race was classified into white, black/African-American, Asian, and unknown/other. 
Ethnicity was classified into Hispanic, non-Hispanic, and unknown.
Geocoding, area socioeconomic measures, and population data
For each ALS case, the patient’s address as provided by the reporting neurologist was 
geocoded using both ArcGIS 10.1 software (ESRI, Redlands, California) and Google Earth 
software, version 7.1 (Google Inc., Mountain View, California). ArcGIS successfully 
geocoded the full addresses of 425 of the 493 cases with a perfect match score, and the 
remaining 68 addresses were manually geocoded using Google Earth. In total, 5 of the 493 
addresses could not be geocoded based on the full address. All geocoded cases were 
assigned a 2010 census tract, and the remaining cases not geocoded (n = 5) were assigned a 
census tract based on their zip code using geographic imputation methods described 
previously by Henry and Boscoe (42).
Census-tract median annual household income was used as the area-based SES measure (43) 
and was categorized into quartiles (1 = lowest, 4 = highest) on the basis of the statewide 
distribution among census tracts. A quartile value was assigned to each ALS case based on 
its census tract. For this analysis, census-tract median income was conceptualized as an area- 
or neighborhood-based socioeconomic measure. Area-based SES measures describe the 
neighborhood context in which an individual lives and could affect health through several 
pathways, including the physical conditions of the neighborhood (e.g., pollution levels), the 
material resources of the neighborhood (e.g., availability of healthy, affordable food 
options), and social capital and social networks (e.g., social contagion, similar norms of 
behavior) (32, 33, 44).
Population counts by age, sex, race, and ethnicity for census tracts used in subsequent 
analyses were obtained from the 2010 US Census (Summary File 1, tables PCT012A–
PCT012H) (45). Because population estimates for census tracts were not available for 
intercensal years, the 2010 population counts were multiplied by 3 to estimate the 
population at risk of ALS for the 3-year period 2009–2011.
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Average annual ALS incidence rates per 100,000 population were age-standardized to the 
2000 US Census population (19 age groups) by means of the direct method. Rates are 
presented as number of cases per 100,000 population, and 95% confidence intervals for 
incidence rates were calculated as gamma intervals (46). The risk of ALS by quartile of 
census-tract median income was estimated using a Poisson regression model adjusting for 
sex, age at diagnosis, and race. Coefficients were exponentiated and interpreted as relative 
risks, and ALS risk in each of the 3 highest income quartiles was compared with that in the 
lowest income quartile. The natural logarithm of the tract-level population in each sex, race, 
and age category was used as an offset in the model. Cases with missing information on race 
(n = 27) were not included in the model. SAS (SAS Institute, Inc., Cary, North Carolina) 
was used to calculate age-adjusted rates, and SAS Proc Glimmix was used to estimate 
parameters in the Poisson regression model. All tests of statistical significance and 
confidence intervals were 2-sided. A P value less than 0.05 was considered statistically 
significant.
Geographic clustering and mapping
Geographic clustering of ALS was evaluated with a spatial scan statistic using SaTScan 
software, version 9.3 (47). The spatial scan statistic is used to test whether a disease is 
randomly distributed over space or whether there is evidence of clustering. Analysis was 
conducted at the census-tract level using a Poisson model and an elliptical spatial window 
with the maximum cluster size set to 50% of the population at risk. We also conducted 
sensitivity analyses of the scan statistic results by setting the maximum cluster size to 10% 
and 5% of the population at risk, respectively. The ALS incidence rates used in the spatial 
scan statistic were adjusted for sex and age (19 age groups), followed by subsequent 
analyses that also adjusted for race. SaTScan reports the geographic area that is the most 
likely cluster and also tests for statistical significance via Monte Carlo simulations (48). Any 
secondary clusters whose P values are below the set α level are also reported. The level of 
statistical significance (α) was set at 0.05 (5%), and 9,999 Monte Carlo iterations were used 
(48). Analyses were completed for all cases combined and for males and females separately.
A geographically smoothed relative risk map of ALS for New Jersey was developed using a 
structured additive regression model based on a fully Bayesian approach. The ALS case 
counts by census tract were modeled as a Poisson random variable. The model included sex, 
age at diagnosis (categorized into 19 age groups), the structured spatial effects, and the 
unstructured random effects (census tracts). The spatial smoothness “prior” was specified 
based on Markov random fields with geographic neighbors defined as those census tracts 
that shared a common boundary. The offset was the natural logarithm of the tract-level 
population in each sex and age category from 2009 through 2011. Positive hyperparameters 
(a = b = 0.001), which are assumed to have an inverse gamma distribution, were chosen to 
ensure the propriety of the joint posterior. The model was fitted by full Bayesian inference 
using Markov chain Monte Carlo simulation methods that allow for random samples to be 
drawn from posterior distributions. A total of 25,000 iterations were run, with the first 5,000 
samples used as the burn-in period, and a final sample of 1,000 was used for posterior 
estimates. The posterior distribution was used to obtain the 95% credible intervals, and the 
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posterior mean value for each tract was exponentiated to obtain the relative risk of ALS. 
Credible intervals, which are analogous to confidence intervals in frequentist statistics, 
describe the range in which a posterior probability estimate is likely to reside and can be 
used to determine whether the relative risk at a specific geographic location is significantly 
different from the statewide risk of ALS (e.g., clustering of high rates). Bayesian analysis 
was performed using the free software BayesX, version 2.1 (Ludwig-Maximilians 
University Munich, Göttingen, Germany) (49), and tract relative risk estimates were mapped 
using ArcGIS 10.1.
RESULTS
A total of 493 ALS cases were diagnosed between 2009 and 2011. The crude ALS incidence 
rate for the study period was 1.87 cases per 100,000 population, and the direct age-
standardized incidence rate was 1.67 cases per 100,000 population. ALS incidence rates 
increased with age up to age 79 years (Table 1), and age-adjusted incidence rates were 
statistically significantly higher for men than for women (P < 0.05) (Table 2). The overall 
age-adjusted incidence rate for whites (1.80 cases per 100,000 population, 95% confidence 
interval (CI): 1.62, 1.97) was statistically significantly higher than that for blacks and Asians 
(P < 0.05). Age-adjusted incidence rates were highest in the highest income quartile and 
decreased for each lower quartile of median income (Table 2).
Table 3 shows the results from the Poisson regression models examining the association 
between ALS risk and census-tract median income. In the crude model and in the model 
adjusted only for age, the risk of ALS was significantly higher in the highest income quartile 
compared with the lowest (relative risks were 1.65 (95% CI: 1.25, 2.18) and 1.55 (95% CI: 
1.18, 2.05), respectively). After adjustment for age, sex, and race, the relative risk of ALS 
was attenuated slightly but remained significantly higher in the highest income quartile 
versus the lowest (relative risk = 1.37, 95% CI: 1.02, 1.82). The fully adjusted model also 
showed that the risk of ALS was significantly higher among men compared with women and 
lower among blacks and Asians compared with whites.
Using the spatial scan statistic, analysis of geographic clustering of ALS indicated no 
statistically significant geographic clusters of elevated ALS risk in New Jersey, either for all 
cases combined or for males and females separately. Furthermore, sensitivity analyses of the 
spatial scan statistic results using smaller spatial windows also indicated no significant 
clusters. The age-adjusted smoothed relative risk map of ALS for New Jersey by census 
tract showed that ALS incidence varied within and across counties. Age-adjusted smoothed 
relative risk estimates ranged from 0.75 to 1.42 (Figure 1). Generally, the relative risk of 
ALS was below 1.0 (lower risk than the statewide average) in lower-income areas of the 
state (Trenton, Camden, Atlantic City, Newark, and Jersey City) and above 1.0 (higher risk 
than the statewide average) in higher-income areas of the state (parts of Bergen, Morris, and 
Monmouth counties) (Figure 1). The 95% credible interval from the Bayesian structured 
additive regression models also indicated that there were no areas where the relative risk of 
ALS was higher than the statewide average (i.e., no significant clustering of ALS).
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To our knowledge, this is the first statewide population-based study completed in the United 
States to have assessed geographic clustering of ALS and to have described the relative risk 
of ALS by geography and area-based SES. The geographic cluster analysis did not identify 
any places in New Jersey where the relative risk of ALS (observed number of cases vs. 
expected number of cases) was statistically significantly high; however, the smoothed 
relative risk maps did identify distinct regional differences in ALS risk throughout the state. 
The results from the multivariable regression models indicated a statistically significant 
association between area-based median income and ALS risk in New Jersey independent of 
age, sex, and race. ALS risk was highest among persons living in areas of the state with the 
highest median income compared with those living in areas with the lowest median income.
Not finding any statistically significant geographic clustering of ALS cases in New Jersey is 
in contrast to many population-based studies completed in other parts of the world (23–26, 
29, 50), including one in the United States that found geographic clustering of ALS (21, 27, 
28). There are several possible reasons why there was no evidence of geographic clustering 
of ALS in New Jersey. First, environmental exposures or other risk factors could be present 
in the other study regions that are not present in New Jersey. Second, the ALS cases in our 
study were more contemporary incident cases diagnosed between 2009 and 2011, while 
many other studies used ALS cases or deaths from earlier time periods. It is possible that 
there may be period and cohort effects where the risk of ALS may vary by time period or 
year of birth, which could coincide with shifts in exposure to risk factors over time. For 
example, in Guam, rates of ALS were extremely high among its indigenous people, the 
Chamorro, in the 1950s (estimated to be 50–100 times higher than worldwide rates), 
followed by decades of significant decline, with rates today that are only slightly higher than 
those worldwide (18). It has been suggested that the decline in ALS rates in Guam was 
related to modernization, which resulted in the elimination of the environmental factors that 
had triggered the high rates (18).
The positive association between area-based SES and ALS risk is an intriguing finding, but 
the underlying factors that may account for this association are unknown. It is possible that 
area-based median income could be correlated with specific behavioral risk factors that 
modify the risk of ALS. It is also possible that differences in residential location based on 
income could account for differential exposures to environmental risk factors that are 
hypothesized to be associated with ALS, including pesticides (51, 52) or the cyanobacteria-
produced neurotoxin β-methylamino-L-alanine (BMAA) (53–56), which is most commonly 
found in marine and freshwater environments (57). More research is needed to understand 
what it is about census-tract median income that produces variability in risk of ALS in New 
Jersey. Because both individual and environmental factors have been suggested as possible 
causes of ALS, future studies should include both individual and area-level measures of 
SES, behavior, and environment.
Of the previous 3 studies that examined SES and ALS risk in the United States, Italy, and 
Finland (37–39), our findings were consistent with only 1: the nationwide study that 
examined mortality rates for motor neuron disease in the United States (38). In that study, 
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Bharucha et al. (38) found that SES, as defined by county-level education, was positively 
associated with motor neuron disease. In the study in Italy, Bracco et al. (39) found that the 
incidence of ALS was highest among manual workers, but they did not find significant 
differences based on educational level. Finally, in Finland, Palo and Jokelainen (37) reported 
that social class was negatively associated with ALS incidence, in contrast with our findings. 
Variations between the studies carried out in the United States, Italy, and Finland—countries 
whose social, economic, and demographic profiles vary greatly—make comparisons 
difficult, and the differences in how SES was operationalized in each one exacerbate the 
problem. These issues point to the need for additional studies to assess the SES-ALS 
relationship, as well as to determine whether our finding of a positive association with SES 
is unique to New Jersey.
A rigorous case ascertainment approach was employed to capture ALS cases for the New 
Jersey ALS surveillance project; however, it is important to consider potential study biases 
related to any unreported ALS cases during the study period. As part of the case capture 
strategy in New Jersey, which has been previously described (13), neurologists in New 
Jersey and in parts of the surrounding states of New York, Pennsylvania, and Delaware 
submitted 109% of the expected number of cases for the 3-year reporting period. New Jersey 
death certificate and hospital discharge data were also used to identify possibly unreported 
cases. Although approximately 10% of neurologists who said they diagnosed or cared for 
ALS patients did not submit case reports, the majority of ALS patients are treated at ALS 
referral centers, and all ALS referral centers in the region reported cases. However, it is 
possible that a small number of cases may have gone unreported. If the unreported cases 
were not missing at random or differential by SES, the direction of the potential bias would 
depend on whether the high- or low-SES groups were more likely to be captured.
In this study, we also investigated the potential for bias to affect estimates of SES and ALS 
due to the exclusion of 27 cases that either had unknown race or were coded as other race. 
Of the 27 cases, 38.1% and 26.7% were in the 2 highest SES groups, respectively. The 
inclusion of these cases would have resulted in a stronger association between SES and 
ALS, and therefore their exclusion in our analysis biased the result toward the null. We also 
conducted 2 additional regression analyses by including only whites and mutually exclusive 
race/ethnicity groups in the models. Both analyses found a significant positive association 
between SES and ALS risk.
There are several limitations to be noted regarding this investigation. First, the geographic 
locations of the cases might not have been their addresses at the time of diagnosis, as 
neurologists were instructed to report the most recent address that was in the medical record. 
Therefore, if patients moved after diagnosis and neurologists updated the medical records, it 
is possible that some addresses might not have represented the case’s address at the time of 
diagnosis. Second, using only residential address at the time of diagnosis limits a study’s 
ability to assess clustering based on past exposures, which may be measured through 
previous residential locations. This is especially important for a disease such as ALS, where 
some studies have suggested a lag time between exposure to a causative agent and the 
development of clinical symptoms (58, 59). To better assess geographic exposures over 
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time, future investigators should consider lifetime residential histories when conducting 
spatial analysis.
In conclusion, no statistically significant geographic clusters of ALS were found in this 
study. However, ALS risk did vary geographically throughout New Jersey and appeared to 
be associated with area-based SES and race. Men and women living in the wealthiest or 
highest-income areas of the state had a higher risk of ALS than those living in lower-income 
areas. The variations we observed in incidence rates by race, area-based SES, and geography 
could be indicative of differential exposures to relevant environmental factors, with respect 
to person or place. Further research is needed to clarify the area-based SES-ALS 
relationship and to determine what other factors, including behavioral, environmental, 
oroccupational health risk factors, might be contributing to the observed geographic 
variation in ALS in New Jersey.
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Geographically smoothed relative risk map of amyotrophic lateral sclerosis (ALS) in New 
Jersey, 2009–2011. The map is based on results from a Bayesian geoadditive model with 
adjustment for age and sex.
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Table 1
Age-Specific Crude Incidence Rates of Amyotrophic Lateral Sclerosis for Cases Diagnosed in New Jersey in 
2009–2011 (n = 493)
Age at Diagnosis, years No. of Cases % Crude IRa
 <30 4 0.8 0.04
 30–39 13 2.6 0.38
 40–49 40 8.1 0.98
 50–59 114 23.1 3.06
 60–69 143 29.0 5.73
 70–79 119 24.1 8.33
 ≥80 60 12.2 5.57
Abbreviation: IR, incidence rate.
a
Number of cases per 100,000 population.
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Table 2
Age-Adjusted Incidence Rates of Amyotrophic Lateral Sclerosis for Cases Diagnosed in New Jersey in 2009–
2011 (n = 493), by Sex, Race, Ethnicity, and Census-Tract Income Quartile
Characteristic No. of Cases % Age-Adjusteda IRb 95% CI
Total 493 100.0 1.67 1.52, 1.82
Sex
 Female 228 46.2 1.42 1.24, 1.62
 Male 265 53.8 1.96 1.73, 2.22
Race
 White 413 83.8 1.80 1.62, 1.97
 Black 31 6.3 0.88 0.57, 1.20
 Asian 22 4.5 1.11 0.63, 1.60
 Other 6 1.2 NCc
 Unknown 21 4.3 NCc
Ethnicityd
 Hispanic 30 6.1 0.93 0.58, 1.30
 Non-Hispanic 438 88.8 1.66 1.50, 1.82
Quartile of census-tract area-based SES (average annual income; range)
 1 ($40,283; $11,193–$51,422) 78 15.8 1.34 1.06, 1.67
 2 ($61,370; $51,613–$71,058) 98 19.9 1.38 1.12, 1.68
 3 ($82,104; $71,188–$95,000) 129 26.2 1.62 1.35, 1.93
 4 ($122,329; $95,072–$250,001) 188 38.1 2.23 1.91, 2.58
Abbreviations: CI, confidence interval; IR, incidence rate; NC, not calculated; SES, socioeconomic status.
a
Directly age-adjusted to the 2000 US Standard Population.
b
Incidence rates per 100,000 population were age-standardized to the 2000 US Standard Population by means of the direct method.
c
Denominator was not available for estimation of age-adjusted rates.
d
Data on ethnicity were missing for 25 cases.
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